HI
WST icon

Horizon Investments’s West Pharmaceutical WST Stock Holding History

Horizon Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$757K Buy
3,024
+74
+3% +$18.4K 0.01% 739
2025
Q4 		$811K Sell
2,950
-61
-2% -$16.7K 0.01% 689
2025
Q3 		$789K Sell
3,011
-178
-6% -$43.3K 0.01% 687
2025
Q2 		$697K Buy
3,189
+2,141
+204% +$458K 0.01% 659
2025
Q1 		$234K Buy
1,048
+57
+6% +$15.7K 0.01% 516
2024
Q4 		$324K Buy
991
+7
+0.7% +$2.2K 0.01% 441
2024
Q3 		$295K Sell
984
-37
-4% -$11.3K 0.01% 459
2024
Q2 		$336K Sell
1,021
-3
-0.3% -$1.06K 0.01% 433
2024
Q1 		$405K Buy
1,024
+2
+0.2% +$740 0.01% 393
2023
Q4 		$360K Sell
1,022
-43
-4% -$15.2K 0.01% 388
2023
Q3 		$399K Sell
1,065
-10
-0.9% -$3.87K 0.01% 352
2023
Q2 		$411K Buy
1,075
+106
+11% +$37.9K 0.01% 347
2023
Q1 		$336K Sell
969
-294
-23% -$85.9K 0.01% 375
2022
Q4 		$297K Buy
+1,263
New +$299K 0.01% 464
2022
Q3 		– Sell
-682
Closed -$206K – 528
2022
Q2 		$206K Sell
682
-19
-3% -$6.18K 0.01% 450
2022
Q1 		$288K Sell
701
-435
-38% -$170K 0.01% 452
2021
Q4 		$533K Buy
1,136
+568
+100% +$244K 0.02% 309
2021
Q3 		$241K Sell
568
-309
-35% -$130K 0.01% 435
2021
Q2 		$315K Sell
877
-939
-52% -$310K 0.01% 389
2021
Q1 		$512K Sell
1,816
-720
-28% -$206K 0.02% 293
2020
Q4 		$718K Buy
2,536
+437
+21% +$123K 0.82% 40
2020
Q3 		$577K Buy
+2,099
New +$555K 0.02% 257

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Horizon Investments's WST Position: Q1 2026 in Review

Horizon Investments increased its West Pharmaceutical (WST) stake by 2.5% in Q1 2026, buying an estimated $18.4K and bringing the position to 3,024 shares worth $757K. The position accounts for 0.01% of the portfolio, ranked #739.

Horizon Investments first reported a position in WST in Q3 2020 and has held it in 22 quarters since. The position peaked at $811K in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Horizon Investments held 3,024 shares of West Pharmaceutical worth $757K as of Q1 2026.
  • Horizon Investments bought 74 West Pharmaceutical shares in Q1 2026, an estimated $18.4K.
  • West Pharmaceutical made up 0.01% of Horizon Investments's portfolio in Q1 2026, its #739 holding.
  • Horizon Investments first reported a position in West Pharmaceutical in Q3 2020 and has held it in 22 quarters since.
  • Horizon Investments's West Pharmaceutical position peaked at $811K in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.